GBP5 Antibody (OTI5C9) [DyLight 650]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-72343C
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human, Monkey
Applications
Flow Cytometry, Immunocytochemistry/ Immunofluorescence
Label
DyLight 650 (Excitation = 652 nm, Emission = 672 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # OTI5C9
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Full length recombinant protein of human GBP5 (NP_443174) produced in HEK293T cells.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for GBP5 Antibody (OTI5C9) [DyLight 650]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: GBP5
Alternate Names
GBP-5, GBP-TA antigen, GTP-binding protein 5, Guanine nucleotide-binding protein 5, guanylate binding protein 5, guanylate-binding protein 5
Gene Symbol
GBP5
Additional GBP5 Products
Product Documents for GBP5 Antibody (OTI5C9) [DyLight 650]
Product Specific Notices for GBP5 Antibody (OTI5C9) [DyLight 650]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...